Report Detail
Global Nuclear Medicine Market Insights, Forecast to 2025
- RnM3061353 |
- 05 March, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.
The global Nuclear Medicine market is valued at 4590 million US$ in 2018 and will reach 7580 million US$ by the end of 2025, growing at a CAGR of 7.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine market based on company, product type, end user and key regions.
This report studies the global market size of Nuclear Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Medicine in these regions.
This research report categorizes the global Nuclear Medicine market by top players/brands, region, type and end user. This report also studies the global Nuclear Medicine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Market size by Product
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Market size by End User
Diagnostic
Therapeutic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Nuclear Medicine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Nuclear Medicine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nuclear Medicine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Nuclear Medicine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Nuclear Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Nuclear Medicine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Nuclear Medicine Market Size Growth Rate by Product
- 1.4.2 Tc-99
- 1.4.3 I-123/131
- 1.4.4 In-111
- 1.4.5 Xe-133
- 1.4.6 Th-201
- 1.4.7 Ga-67
- 1.4.8 Other
- 1.5 Market by End User
- 1.5.1 Global Nuclear Medicine Market Size Growth Rate by End User
- 1.5.2 Diagnostic
- 1.5.3 Therapeutic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Nuclear Medicine Market Size
- 2.1.1 Global Nuclear Medicine Revenue 2014-2025
- 2.1.2 Global Nuclear Medicine Sales 2014-2025
- 2.2 Nuclear Medicine Growth Rate by Regions
- 2.2.1 Global Nuclear Medicine Sales by Regions
- 2.2.2 Global Nuclear Medicine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Nuclear Medicine Sales by Manufacturers
- 3.1.1 Nuclear Medicine Sales by Manufacturers
- 3.1.2 Nuclear Medicine Sales Market Share by Manufacturers
- 3.1.3 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
- 3.2 Nuclear Medicine Revenue by Manufacturers
- 3.2.1 Nuclear Medicine Revenue by Manufacturers (2014-2019)
- 3.2.2 Nuclear Medicine Revenue Share by Manufacturers (2014-2019)
- 3.3 Nuclear Medicine Price by Manufacturers
- 3.4 Nuclear Medicine Manufacturing Base Distribution, Product Types
- 3.4.1 Nuclear Medicine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Nuclear Medicine Product Type
- 3.4.3 Date of International Manufacturers Enter into Nuclear Medicine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Nuclear Medicine Sales by Product
- 4.2 Global Nuclear Medicine Revenue by Product
- 4.3 Nuclear Medicine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Nuclear Medicine Breakdown Data by End User
6 North America
- 6.1 North America Nuclear Medicine by Countries
- 6.1.1 North America Nuclear Medicine Sales by Countries
- 6.1.2 North America Nuclear Medicine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Nuclear Medicine by Product
- 6.3 North America Nuclear Medicine by End User
7 Europe
- 7.1 Europe Nuclear Medicine by Countries
- 7.1.1 Europe Nuclear Medicine Sales by Countries
- 7.1.2 Europe Nuclear Medicine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Nuclear Medicine by Product
- 7.3 Europe Nuclear Medicine by End User
8 Asia Pacific
- 8.1 Asia Pacific Nuclear Medicine by Countries
- 8.1.1 Asia Pacific Nuclear Medicine Sales by Countries
- 8.1.2 Asia Pacific Nuclear Medicine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Nuclear Medicine by Product
- 8.3 Asia Pacific Nuclear Medicine by End User
9 Central & South America
- 9.1 Central & South America Nuclear Medicine by Countries
- 9.1.1 Central & South America Nuclear Medicine Sales by Countries
- 9.1.2 Central & South America Nuclear Medicine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Nuclear Medicine by Product
- 9.3 Central & South America Nuclear Medicine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Nuclear Medicine by Countries
- 10.1.1 Middle East and Africa Nuclear Medicine Sales by Countries
- 10.1.2 Middle East and Africa Nuclear Medicine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Nuclear Medicine by Product
- 10.3 Middle East and Africa Nuclear Medicine by End User
11 Company Profiles
- 11.1 GE Healthcare
- 11.1.1 GE Healthcare Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GE Healthcare Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GE Healthcare Nuclear Medicine Products Offered
- 11.1.5 GE Healthcare Recent Development
- 11.2 Bracco Imaging
- 11.2.1 Bracco Imaging Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bracco Imaging Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bracco Imaging Nuclear Medicine Products Offered
- 11.2.5 Bracco Imaging Recent Development
- 11.3 Mallinckrodt
- 11.3.1 Mallinckrodt Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Mallinckrodt Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Mallinckrodt Nuclear Medicine Products Offered
- 11.3.5 Mallinckrodt Recent Development
- 11.4 Lantheus Medical Imaging
- 11.4.1 Lantheus Medical Imaging Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Lantheus Medical Imaging Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Lantheus Medical Imaging Nuclear Medicine Products Offered
- 11.4.5 Lantheus Medical Imaging Recent Development
- 11.5 Bayer
- 11.5.1 Bayer Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bayer Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bayer Nuclear Medicine Products Offered
- 11.5.5 Bayer Recent Development
- 11.6 Triad Isotopes
- 11.6.1 Triad Isotopes Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Triad Isotopes Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Triad Isotopes Nuclear Medicine Products Offered
- 11.6.5 Triad Isotopes Recent Development
- 11.7 Nordion
- 11.7.1 Nordion Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Nordion Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Nordion Nuclear Medicine Products Offered
- 11.7.5 Nordion Recent Development
- 11.8 Jubilant Pharma
- 11.8.1 Jubilant Pharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Jubilant Pharma Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Jubilant Pharma Nuclear Medicine Products Offered
- 11.8.5 Jubilant Pharma Recent Development
- 11.9 Eli Lilly
- 11.9.1 Eli Lilly Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Eli Lilly Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Eli Lilly Nuclear Medicine Products Offered
- 11.9.5 Eli Lilly Recent Development
- 11.10 SIEMENS
- 11.10.1 SIEMENS Company Details
- 11.10.2 Company Business Overview
- 11.10.3 SIEMENS Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 SIEMENS Nuclear Medicine Products Offered
- 11.10.5 SIEMENS Recent Development
- 11.11 China Isotope & Radiation
- 11.12 Dongcheng
12 Future Forecast
- 12.1 Nuclear Medicine Market Forecast by Regions
- 12.1.1 Global Nuclear Medicine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Nuclear Medicine Revenue Forecast by Regions 2019-2025
- 12.2 Nuclear Medicine Market Forecast by Product
- 12.2.1 Global Nuclear Medicine Sales Forecast by Product 2019-2025
- 12.2.2 Global Nuclear Medicine Revenue Forecast by Product 2019-2025
- 12.3 Nuclear Medicine Market Forecast by End User
- 12.4 North America Nuclear Medicine Forecast
- 12.5 Europe Nuclear Medicine Forecast
- 12.6 Asia Pacific Nuclear Medicine Forecast
- 12.7 Central & South America Nuclear Medicine Forecast
- 12.8 Middle East and Africa Nuclear Medicine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Nuclear Medicine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Nuclear Medicine . Industry analysis & Market Report on Nuclear Medicine is a syndicated market report, published as Global Nuclear Medicine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Nuclear Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
